Toxin-Antitoxin Systems: A Tool for Taxonomic Analysis of Human Intestinal Microbiota.


Journal

Toxins
ISSN: 2072-6651
Titre abrégé: Toxins (Basel)
Pays: Switzerland
ID NLM: 101530765

Informations de publication

Date de publication:
12 06 2020
Historique:
received: 06 05 2020
revised: 08 06 2020
accepted: 10 06 2020
entrez: 18 6 2020
pubmed: 18 6 2020
medline: 3 3 2021
Statut: epublish

Résumé

The human gastrointestinal microbiota (HGM) is known for its rich diversity of bacterial species and strains. Yet many studies stop at characterizing the HGM at the family level. This is mainly due to lack of adequate methods for a high-resolution profiling of the HGM. One way to characterize the strain diversity of the HGM is to look for strain-specific functional markers. Here, we propose using type II toxin-antitoxin systems (TAS). To identify TAS systems in the HGM, we previously developed the software TAGMA. This software was designed to detect the TAS systems, MazEF and RelBE, in lactobacilli and bifidobacteria. In this study, we updated the gene catalog created previously and used it to test our software anew on 1346 strains of bacteria, which belonged to 489 species and 49 genera. We also sequenced the genomes of 20 fecal samples and analyzed the results with TAGMA. Although some differences were detected at the strain level, the results showed no particular difference in the bacterial species between our method and other classic analysis software. These results support the use of the updated catalog of genes encoding type II TAS as a useful tool for computer-assisted species and strain characterization of the HGM.

Identifiants

pubmed: 32545455
pii: toxins12060388
doi: 10.3390/toxins12060388
pmc: PMC7354421
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Russian Foundation for Basic Research
ID : 18-34-00011
Pays : International
Organisme : Russian Science Foundation
ID : 19-74-00146
Pays : International

Références

PLoS One. 2013 May 23;8(5):e64315
pubmed: 23717595
Nat Methods. 2012 Jun 10;9(8):811-4
pubmed: 22688413
J Bacteriol. 2020 Mar 11;202(7):
pubmed: 31932311
Nucleic Acids Res. 2011 Jul;39(13):5513-25
pubmed: 21422074
Cell. 2012 Mar 16;148(6):1258-70
pubmed: 22424233
Genome Med. 2016 Apr 20;8(1):41
pubmed: 27098841
RNA Biol. 2017 Mar 4;14(3):275-280
pubmed: 28067598
Nat Commun. 2019 Nov 6;10(1):5029
pubmed: 31695033
Anaerobe. 2013 Aug;22:82-9
pubmed: 23727113
Microbiome. 2018 May 24;6(1):94
pubmed: 29793532
Nature. 2011 May 12;473(7346):174-80
pubmed: 21508958
Arch Microbiol. 2017 Jul;199(5):683-690
pubmed: 28213763
FEMS Microbiol Rev. 2017 Jul 1;41(4):453-478
pubmed: 28333226
J Bacteriol. 2014 Jun;196(11):2053-66
pubmed: 24659771
Cell Host Microbe. 2020 Mar 11;27(3):467-475.e6
pubmed: 32075742
J Allergy Clin Immunol. 2007 Aug;120(2):343-50
pubmed: 17604093
Genetika. 2013 Mar;49(3):315-27
pubmed: 23755531
Genome Res. 2016 Dec;26(12):1721-1729
pubmed: 27852649
Front Microbiol. 2016 Apr 20;7:459
pubmed: 27148170
Biochem J. 2017 May 16;474(11):1823-1836
pubmed: 28512250
Biochim Biophys Acta. 2013 Jun;1834(6):1155-67
pubmed: 23459128
Nature. 2017 Oct 5;550(7674):61-66
pubmed: 28953883
J Mol Biol. 2007 Sep 28;372(4):894-905
pubmed: 17706670
PeerJ. 2019 Mar 4;7:e6554
pubmed: 30863681
Toxins (Basel). 2019 May 09;11(5):
pubmed: 31075979
Nucleic Acids Res. 2005 Feb 17;33(3):966-76
pubmed: 15718296
Nucleic Acids Res. 2016 Jan 4;44(D1):D279-85
pubmed: 26673716
Front Mol Biosci. 2016 Mar 22;3:9
pubmed: 27047942
J Basic Microbiol. 2015 Aug;55(8):982-91
pubmed: 25832734
J Bacteriol. 2013 Jul;195(14):3165-72
pubmed: 23667234
Biol Direct. 2009 Jun 03;4:19
pubmed: 19493340
Nat Med. 2018 Apr 10;24(4):392-400
pubmed: 29634682
Mol Cell. 2018 Jun 7;70(5):768-784
pubmed: 29398446
Genome Biol. 2019 Nov 28;20(1):257
pubmed: 31779668

Auteurs

Ksenia M Klimina (KM)

Vavilov Institute of General Genetics Russian Academy of Sciences, 119991 Moscow, Russia.
Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, 119435 Moscow, Russia.

Viktoriya N Voroshilova (VN)

Vavilov Institute of General Genetics Russian Academy of Sciences, 119991 Moscow, Russia.
Moscow Institute of Physics and Technology, Dolgoprudny, 141701 Moscow, Russia.

Elena U Poluektova (EU)

Vavilov Institute of General Genetics Russian Academy of Sciences, 119991 Moscow, Russia.

Vladimir A Veselovsky (VA)

Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, 119435 Moscow, Russia.

Roman A Yunes (RA)

Vavilov Institute of General Genetics Russian Academy of Sciences, 119991 Moscow, Russia.

Aleksey S Kovtun (AS)

Vavilov Institute of General Genetics Russian Academy of Sciences, 119991 Moscow, Russia.
Moscow Institute of Physics and Technology, Dolgoprudny, 141701 Moscow, Russia.

Anna V Kudryavtseva (AV)

Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia.

Artem S Kasianov (AS)

Vavilov Institute of General Genetics Russian Academy of Sciences, 119991 Moscow, Russia.
Moscow Institute of Physics and Technology, Dolgoprudny, 141701 Moscow, Russia.

Valery N Danilenko (VN)

Vavilov Institute of General Genetics Russian Academy of Sciences, 119991 Moscow, Russia.
Faculty of Ecology, International Institute for Strategic Development of Sectoral Economics, Peoples' Friendship University of Russia (RUDN University), 117198 Moscow, Russia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH